Literature DB >> 22087146

Pernicious anemia in case of chronic viral hepatitis infection: Pernicious anemia and chronic viral hepatitis.

Emmanuel Andres1, Mustapha Mecili, Ecaterina Ciobanu.   

Abstract

Entities:  

Keywords:  Cobalamin deficiency; Hepatitis B; Hepatitis C; Interferon-alpha; Pernicious anemia; Viral hepatitis

Year:  2011        PMID: 22087146      PMCID: PMC3206689     

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


× No keyword cloud information.
Dear Editor, Leonardi and Rosa's (2010) research on the link between celiac disease and viral hepatitis [1] is well designed and focuses on a very interesting topic. Several de novo or latent autoimmune disorders or diseases have been reported in cases of chronic viral hepatitis infections, especially Hepatitis C [2]. In this paper, we report 5 cases of established pernicious anemia during chronic viral hepatitis infection. These cases were extracted from a retrospective (1996 to 2010) study of 82 cases of pernicious anemia in the University Hospital of Strasbourg, France, a tertiary reference center (personal communication in the French Congress of Hematology, Paris, December, 2010). Clinical characteristics of the 5 patients are described in table 1, particularly details on hepatitis infection, modalities of the interferon-alpha treatment, and data on the cobalamin deficiency related to the pernicious anemia. Data of 3 patients were previously published in the literature [3]. It is important to note that, in one case, an association was found between pernicious anemia, true celiac disease, and chronic actve Hepatitis C infection. All the patients were successfully treated with regular intramuscular cyanocobalamin therapy (despite continuous administration of interferon-alpha in 2 cases). To the best of our knowledge, there are only a relatively small amount of cases (< 10 in our own data) documenting a relationship between symptomatic pernicious anemia and viral hepatitis infections. Our patients had established pernicious anemia with documented cobalamin deficiency (in accordance with recent criteria; [4]). They alsfo have a clear chronic active viral hepatitis infection on liver biopsy (1 case of Hepatitis B and 4 cases of Hepatitis C). Moreover, one of our patients had a well-documented case of celiac disease with malabsorption and antitransglutamise antibodies, partially cured with nutritional restrictions (no gluten intake). The pathogenis (the link) of this association is not well knownf, but the role of the virus or of the interferon-alpha treatment as an immuno-modulatory agent is possible [5]. However in our opinion, the fact that this association is exceptional led to the suspicion of a fortuitous association. Thus before any conclusions can be made, future studies similar to Leaonardi and Rosa (2010) are required. Nevertheless, it is important to be aware of the possibility of the association between pernicious anemia and chronic viral hepatitis infections because recognition of this association can help prevent severe cobalamin deficiency.
Table 1

Characteristics of the patients

Age (years), sexData on viral hepatitisData on cobalamin deficiency related to pernicious anemiaOther autoimmune disorders
52, FChronic active hepatitis B followed since at least 5 years of age with no treatmentCobalamin deficiency:Hashimoto’s thyroïd with anti-TPO antibodies a
• Loss of reflexes
• Megaloblastic anemia
• Serum vitamin B12 level <130 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Autoimmune atrophic gastritis
45, MChronic active hepatitis C followed since 5 years of age and treated with interféron-α: 9 MU per week (subcutaneously)Cobalamin deficiency:-
• Medullar combined sclerosis
• No hematological abnormality
• Serum vitamin B12 level <22 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Malabsorption on the de Schilling’s test reversed with intrinsic factor b
• Autoimmune atrophic gastritis
58, FChronic active hepatitis C treated since 7 months of age with interféron-α: 9 MU per week (subcutaneously)Cobalamin deficiency:Asymptomatic cryoglobulinemia
• Loss of reflexes
• Megaloblastic anemia and thrombocytopenia
• Serum vitamin B12 level <150 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
82, MMild chronic hepatitis C with no interferon-alpha treatmentCobalamin deficiency:Antinuclear antibodies a
• Sensitive peripheral neuropathy
• Megaloblastic anemia
• Serum vitamin B12 level <20 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Autoimmune atrophic gastritis
38, MChronic hepatitis C with no interferon-alpha treatmentCobalamin deficiency:Celiac disease with malabsorption (iron, folate and calcium), duodal villous atrophy and antitransglutaminase antibodies a
• Sensitive peripheral neuropathy
• Macrocytosis (MCV = 105 fL)
• Serum vitamin B12 level <160 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a

a Serum vitamin B12 levels were determined by radioimmunoassay (Bayer, New York, NY, USA).

b Schilling’s test was realized with a Dicopac test (Amersham Healthcare, Birmingham UK).

a Serum vitamin B12 levels were determined by radioimmunoassay (Bayer, New York, NY, USA). b Schilling’s test was realized with a Dicopac test (Amersham Healthcare, Birmingham UK).
  4 in total

1.  Pernicious anemia associated with interferon-alpha therapy and chronic hepatitis C infection.

Authors:  Emmanuel Andrès; Noureddine Henoun Loukili; Maher Ben Abdelghani; Esther Noel
Journal:  J Clin Gastroenterol       Date:  2004-04       Impact factor: 3.062

2.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

Authors:  P Cacoub; C Renou; E Rosenthal; P Cohen; I Loury; V Loustaud-Ratti; A M Yamamoto; A C Camproux; P Hausfater; L Musset; P Veyssier; G Raguin; J C Piette
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

3.  Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy.

Authors:  Emmanuel Andrès; Josep Vidal-Alaball; Laure Federici; Noureddine Henoun Loukili; Jacques Zimmer; Georges Kaltenbach
Journal:  Eur J Intern Med       Date:  2007-07-12       Impact factor: 4.487

4.  Are hepatitis B virus and celiac disease linked?

Authors:  Salvatore Leonardi; Mario La Rosa
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

  4 in total
  1 in total

1.  Pernicious anemia associated with cryptogenic cirrhosis: Two case reports and a literature review.

Authors:  Xin Yan; Runping Gao; Yulin Hu; Jinglan Jin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.